The fusion partner specifies the oncogenic potential of NUP98 fusion proteins

Leukemia Research

Volumn 37, Issue 12, 2013, Pages 1668-1673

  Saw, Jesslyn ^a   Curtis, David J ^a   Hussey, Damian J ^b   Dobrovic, Alexander ^c,d   Aplan, Peter D ^e   Slape, Christopher I ^a  

^a MONASH UNIVERSITY   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Homeobox; HOX; Leukemia; NUP98; Translocation

Indexed keywords

DNA TOPOISOMERASE; HOX PROTEIN; HYBRID PROTEIN; NUCLEOPORIN 98; NUP98 HOXD13 FUSION PROTEIN; NUP98 RAP1GDS1 PROTEIN; NUP98 TOP1 FUSION PROTEIN; RAP1 GUANINE TRIPHOSPHATE GUANINE DIPHOSPHATE DISSOCIATION STIMULATOR PROTEIN 1; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; TRANSCRIPTION FACTOR HOXD13; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; AMINO ACID SUBSTITUTION; ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENICITY; CONTROLLED STUDY; FUSION GENE; GENE; GENE EXPRESSION; GENE FUNCTION; HOXD13 GENE; LYMPHOCYTOPENIA; MALIGNANT TRANSFORMATION; MOLECULAR DOCKING; MOUSE; NONHUMAN; NUP98 GENE; NUP98 HOXD13 GENE; NUP98 RAP1GDS1 GENE; NUP98 TOP1 GENE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; RAP1GDS1 GENE; T CELL LEUKEMIA; THROMBOCYTOPENIA; TOP1 GENE; TRANSGENIC MOUSE;

EID: 84888129235     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2013.09.013     Document Type: Article

References (25)

1. Gough S.M., Slape C.I., Aplan P.D. NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights. Blood 2011, 118:6247-6257.
2. de Rooij J.D., Hollink I.H., Arentsen-Peters S.T., van Galen J.F., Berna Beverloo H., Baruchel A., et al. NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern. Leukemia 2013.
3. Hollink I.H., van den Heuvel-Eibrink M.M., Arentsen-Peters S.T., Pratcorona M., Abbas S., Kuipers J.E., et al. NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern. Blood 2011, 118:3645-3656.
4. Kasper L.H., Brindle P.K., Schnabel C.A., Pritchard C.E., Cleary M.L., van Deursen J.M. CREB binding protein interacts with nucleoporin-specific FG repeats that activate transcription and mediate NUP98-HOXA9 oncogenicity. Mol Cell Biol 1999, 19:764-776.
5. Wang G.G., Cai L., Pasillas M.P., Kamps M.P. NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis. Nat Cell Biol 2007, 9:804-812.
6. Wang G.G., Song J., Wang Z., Dormann H.L., Casadio F., Li H., et al. Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger. Nature 2009, 459:847-851.
7. Lin Y.W., Slape C., Zhang Z., Aplan P.D. NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemia. Blood 2005, 106:287-295.
8. Ogilvy S., Metcalf D., Print C.G., Bath M.L., Harris A.W., Adams J.M. Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival. Proc Natl Acad Sci USA 1999, 96:14943-14948.
9. Iwasaki M., Kuwata T., Yamazaki Y., Jenkins N.A., Copeland N.G., Osato M., et al. Identification of cooperative genes for NUP98-HOXA9 in myeloid leukemogenesis using a mouse model. Blood 2005, 105:784-793.
10. Gurevich R.M., Rosten P.M., Schwieger M., Stocking C., Humphries R.K. Retroviral integration site analysis identifies ICSBP as a collaborating tumor suppressor gene in NUP98-TOP1-induced leukemia. Exp Hematol 2006, 34:1192-1201.
11. Raza-Egilmez S.Z., Jani-Sait S.N., Grossi M., Higgins M.J., Shows T.B., Aplan P.D. NUP98-HOXD13 gene fusion in therapy-related acute myelogenous leukemia. Cancer Res 1998, 58:4269-4273.
12. Ahuja H.G., Felix C.A., Aplan P.D. The t(11;20)(p15;q11) chromosomal translocation associated with therapy-related myelodysplastic syndrome results in an NUP98-TOP1 fusion. Blood 1999, 94:3258-3261.
13. Hussey D.J., Nicola M., Moore S., Peters G.B., Dobrovic A. The (4;11)(q21;p15) translocation fuses the NUP98 and RAP1GDS1 genes and is recurrent in T-cell acute lymphocytic leukemia. Blood 1999, 94:2072-2079.
14. Griffis E.R., Altan N., Lippincott-Schwartz J., Powers M.A. Nup98 is a mobile nucleoporin with transcription-dependent dynamics. Mol Biol Cell 2002, 13:1282-1297.
15. Wang J.C. DNA topoisomerases. Annu Rev Biochem 1996, 65:635-692.
16. Mizuno T., Kaibuchi K., Yamamoto T., Kawamura M., Sakoda T., Fujioka H., et al. A stimulatory GDP/GTP exchange protein for smg p21 is active on the post-translationally processed form of c-Ki-ras p21 rhoA. p21. Proc Natl Acad Sci USA 1991, 88:6442-6446.
17. Slape C.I., Saw J., Jowett J.B., Aplan P.D., Strasser A., Jane S.M., et al. Inhibition of apoptosis by BCL2 prevents leukemic transformation of a murine myelodysplastic syndrome. Blood 2012, 120:2475-2483.
18. Choi C.W., Chung Y.J., Slape C., Aplan P.D. A NUP98-HOXD13 fusion gene impairs differentiation of B and T lymphocytes and leads to expansion of thymocytes with partial TCRB gene rearrangement. J Immunol 2009, 183:6227-6235.
19. Novak R.L., Harper D.P., Caudell D., Slape C., Beachy S.H., Aplan P.D. Gene expression profiling and candidate gene resequencing identifies pathways and mutations important for malignant transformation caused by leukemogenic fusion genes. Exp Hematol 2012, 40:1016-1027.
20. Li Z., Zhang Z., Li Y., Arnovitz S., Chen P., Huang H., et al. PBX3 is an important cofactor of HOXA9 in leukemogenesis. Blood 2013, 121:1422-1431.
21. Hussey D.J., Dobrovic A. Recurrent coiled-coil motifs in NUP98 fusion partners provide a clue to leukemogenesis. Blood 2002, 99:1097-1098.
22. Gilliland D.G., Tallman M.S. Focus on acute leukemias. Cancer Cell 2002, 1:417-420.
23. Nguyen A.T., Taranova O., He J., Zhang Y. DOT1L, the H3K79 methyltransferase, is required for MLL-AF9-mediated leukemogenesis. Blood 2011, 117:6912-6922.
24. Argiropoulos B., Humphries R.K. Hox genes in hematopoiesis and leukemogenesis. Oncogene 2007, 26:6766-6776.
25. Thorsteinsdottir U., Mamo A., Kroon E., Jerome L., Bijl J., Lawrence H.J., et al. Overexpression of the myeloid leukemia-associated Hoxa9 gene in bone marrow cells induces stem cell expansion. Blood 2002, 99:121-129.